SEC Form D filing
Qlaris Bio, Inc.
Biotech · Series A · Regulation D 506(b) · MA · Filed June 17, 2026
Offering amount
$3.9M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
June 17, 2026
Signature date
June 16, 2026
CIK
0001786717
Summary
Auto-generatedclinical-stage biotechnology company, $3.9M series-a raise in MA
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.